NIH Pumps $43M into Undiagnosed Diseases Network to Target Rare Disorders with Genomic Medicine | GenomeWeb

NEW YORK (GenomeWeb) – The National Institutes of Health plans has awarded six clinical research institutions $43 million to create a National Human Genome Research Institute-led network that will use genomic medicine to investigate rare and undiagnosed diseases.

NHGRI said today the funding for the Undiagnosed Diseases Network, provided by the NIH Common Fund, expands the Undiagnosed Diseases Program that has been running at the NIH Clinical Center for six years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.